Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8385 USD | +1.70% | +4.63% | -11.49% |
Financials (USD)
Sales 2024 * | 2.33M | Sales 2025 * | 3.33M | Capitalization | 61.04M |
---|---|---|---|---|---|
Net income 2024 * | -102M | Net income 2025 * | -111M | EV / Sales 2024 * | 26.2 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 18.3 x |
P/E ratio 2024 * |
-0.62
x | P/E ratio 2025 * |
-0.67
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.19% |
Latest transcript on Kezar Life Sciences, Inc.
1 day | +1.70% | ||
1 week | +1.51% | ||
Current month | +1.70% | ||
1 month | -7.00% | ||
3 months | -15.26% | ||
6 months | +16.28% | ||
Current year | -11.49% |
Managers | Title | Age | Since |
---|---|---|---|
Christopher Kirk
FOU | Founder | 52 | 15-02-18 |
John Fowler
FOU | Founder | 52 | 15-02-18 |
Marc Belsky
DFI | Director of Finance/CFO | 68 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 16-10-31 |
Graham Cooper
CHM | Chairman | 54 | 17-09-30 |
Michael Kauffman
BRD | Director/Board Member | 60 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.8385 | +1.70% | 967,773 |
24-04-30 | 0.8245 | -1.59% | 634,034 |
24-04-29 | 0.8378 | +4.09% | 597,200 |
24-04-26 | 0.8049 | +1.89% | 496,295 |
24-04-25 | 0.79 | -1.42% | 577,569 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.49% | 60.02M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- KZR Stock